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Summary The reactivity of 95 breast carcinomas with the antibody Ki-67, which recognises a nuclear antigen
in proliferating cells, has been assessed and compared to their histological grade and, for 47 tumours, DNA
index and S-phase content. The effects of freezing and section handling on the stability of the nuclear antigen
have been assessed.
Evidence of nuclear staining was seen in 56% of carcinomas, with a range of positive cells from <1% to
60%. Cytoplasmic rather than nuclear staining was observed in 26% and 18% of carcinomas were negative.
A significant correlation was observed between the presence of nuclear staining and poorer histological grade
and higher S-phase content, and between the percentage of positive nuclei and S-phase content, but not grade.
Three groups of carcinomas were identified: those in which Ki-67 reactivity, grade and S-phase content were
similar; ones in which there was prominent nuclear reactivity with Ki-67 but low grade and S-phase content;
and a group showing the converse. These patients will be followed to assess which of these three markers of
proliferation is of greatest prognostic value.
There is evidence from several independent studies that the
prolifer.ative activity of breast carcinomas is of prognostic
signilficanic (Gentili et al., 1981; Mayer et al., 1983; Tubianai
et al., 1984). Although information can be gained lFrom
mitotic counting of histological sections, this is a tedious
procedure, and measurement of the thymidine labelling index
(TLI) has been used more extensively for asessing pro-
liferation. The technique employs tritiated thymidine
incorporation, with subsequent autoradiography (Mayer &
Connor, 1977), which may restrict the number of
laboratories undertaking this as a routine prognostic marker.
The introduction of DNA flow cytometry, with its ap-
plicability to fixed, paraffin embedded tissue (Hedley et al.,
1983) has proved to be of value in determining S-phase
content of breast carcinomas (Walker & Camplejohn, 1986)
but again there is a restriction in its availability.
The existence of an antibody Ki-67, recognising a nuclear
antigen present in proliferating cells (Gerdes et al., 1983)
which can be applied to frozen sections and detected by the
readily available immuno-histochemical methods is therefore
of potentially wider utility. To assess the value of Ki-67 in
estimating the proliferative activity of breast carcinomas we
have compared Ki-67 reactivity of a group of tumours with
histological grade and S-phase fraction determined by DNA
flow cytometry.
Materials and methods
Tissue was available from 95 breast carcinomas. For all
tumours samples no greater than 1.0 x 0.8 x 0.2cm were
frozen in liquid nitrogen within 20min of excision from the
patient, and stored in the vapour phase of a liquid nitrogen
fridge. Parallel slices were fixed in 4% formaldehyde in
saline and processed to paraffin wax.
For 85 of the carcinomas, tissue was examined after 2 to 9
months storage in liquid nitrogen. The remaining 10 tumours
were immunostained either immediately and/or within 1 to 7
days of surgical excision. For two of these, two and three
separate samples were assessed respectively. In all instances
sections (6-8pm) were cut in a cryostat at -20°C, air dried
for 10min and fixed in acetone for 10min. After blocking
with normal rabbit serum, Ki-67 mouse monoclonal anti-
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body was applied. For the majority of 85 of the carcinomas
the antibody was a gift from Dr J. Gerdes and was applied
at a dilution of 1:500 as recommended, for 60min. Half of
these tumours were also tested with Ki-67 antibody obtained
from Dako Ltd, and for these a dilution of 1:50 was
employed. Both a two stage indirect immunoperoxidase and
a three stage alkaline phosphatase-anti alkaline phosphatase
complex (APAAP) detection system were used, all reagents
being from Dako Ltd. For the 10 carcinomas tested after the
shorter period of storage a second batch of Ki-67 antibody
was obtained from Dako Ltd and the three stage APAAP
method employed. Levamisole was used in all instances to
inhibit endogenous alkaline phosphatase. For some cases the
effect of different periods of air drying of sections prior to
acetone fixation, and of the effect of storage of unfixed
sections at -20°C was assessed.
The percentage of cells with nuclear staining was
determined by counting the number of positive nuclei and
the total number of nuclei in 12 h.p.f. ( x 40 objective, Zeiss
Photomicroscope III), ensuring that the whole section was
scanned. An average of 2,000 nuclei per section were
counted, and if heterogeneity was a feature the number of
h.p.f. assessed was increased.
H&E stained sections of all formalin fixed, paraffin
embedded tissue were assessed for histological grade using a
modification of the Bloom and Richardson criteria (Elston et
al., 1982).
The DNA ploidy and S-phase fraction of 47 of the
carcinomas was undertaken using formalin fixed, paraffin
embedded tissue as described previously (Walker &
Camplejohn, 1986). Briefly, 40,m paraffin sections were
dewaxed, rehydrated and treated with pepsin for 30min at
37°C. After filtration and needling the suspensions were
incubated with 1 pgml-1 DAPI (4'6-diamino-2-pheny-
lindoldihydrochloride, Boehringer) for 30min before analysis.
Samples were assessed with a Becton Dickinson FACS
Analyzer powered by a mercury arc lamp. For each DNA
histogram 10,000-15,000 cells were scanned. The DNA index
was determined and the method for calculating the percen-
tage of cells in S-phase was based on that of Baisch et al.
(1975), where possible. In the presence of DNA aneuploidy
the S-phase fraction was calculated using the average mid-
S-phase height, according to the method described by
Frankfurt et al. (1984). This is applicable when there are
substantial flat zones for both of the S-phase regions on
the plot.
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Results
Ki-67 staining
There was evidence of nuclear staining in 53 of the 95
carcinomas examined (56%). Within individual nuclei the
intensity and extent of staining was variable (Figure 1).
Heterogeneity was a feature, there being in some tumours
clustering of positive nuclei and variable sized negative areas,
whereas in others reactive nuclei were present throughout the
section. In some tumours cytoplasmic staining was seen in
small numbers of cells which did not show nuclear reactivity.
This pattern of cytoplasmic reactivity was the only staining
seen in 25 carcinomas (26%). Whilst in many of these
tumours only less than 5% of cells stained in this way, in
four of the carcinomas the intensity and proportion of cells
was striking as shown in Figure 2. There was no evidence of
staining in seventeen carcinomas (18%).
The extent of nuclear reactivity was divided into four
groups:
<5% of nuclei stained 21/53
5-15% of nuclei stained 16/53
16-25% of nuclei stained 13/53
26-60% of nuclei stained 3/53
The negative results were observed with both the two and
three stage immunohistochemical methods. No significant
differences were observed in the percentage of nuclei stained
between the two methods. The findings for the ten carci-
nomas which had been stained very soon after excision were
compared to those which had been stored for two to nine
months before testing. Two tumours were negative, two had
less than 1% of nuclei reacting and none had more than
15% of nuclei reacting; the 10 included different types and
grades of carcinomas. The only significant difference was in
the lack of cytoplasmic staining of tumour cells. Weak
staining of myoepithelial cells only was observed. With the
two previous batches of antibody strong cytoplasmic staining
of normal ductal and acinar epithelial was a frequent finding
Figure 1 Breast carcinoma stained with Ki-67 demonstrating
the variation in extent and intensity of staining within individual
nuclei (arrowed) (Mag. x 180).
Figure 2 Poorly differentiated breast carcinoma in which groups
of tumour cells show strong cytoplasmic staining with no
reaction in nuclei (arrowed) (Mag. x 120).
as well as the weak myoepithelial staining. No differences
were observed in the proportion of nuclei reacting between
immediate staining and after storage of up to 7 days and
after different periods of air drying of sections. Nuclear
staining persisted after storage of sections at -20°C. No
differences were observed between different samples from
two specimens, one of which was negative in three separate
samples.
Relationship to grade and S-phasefraction
The mean coefficient of variation (CV) for the DNA flow
in Table I. Two carcinomas were predominantly intraduct
and were not graded; both showed cytoplasmic staining.
Three of the seven (43%) well differentiated carcinomas
showed nuclear reactivity in comparison to 49% of the
moderately differentiated, and 78% of the poorly dif-
ferentiated carcinomas. The presence of nuclear staining was
significantly associated with a poorer degree of dif-
ferentiation (0.05>P>0.02; x2 6.78, 2 degrees of freedom).
However, the extent of staining showed no specific cor-
relation with grade.
The mean coefficient of variation (cV) for the DNA flow
cytometry analysis was 4.16+s.e. 0.32. Eight of the
carcinomas analysed were DNA diploid, and two of these
had evidence of nuclear staining. Of the 39 DNA aneuploid
tumours 22 had nuclear staining, 10 cytoplasmic staining and
7 were negative. The relationship between S-phase content
and Ki-67 staining is shown in Table II; the grade of the
carcinomas is also included. The S-phase content was
categorised as low (<7%) medium (7-14%) and high (> 14%).
Two of the 11 carcinomas with low S-phase content exhi-
bited nuclear staining, both ofmoderate differentiation. Forty-
seven percent of tumours with moderate S-phase content
showed nuclear reactivity, whilst 78% of carcinomas with
high S-phase content stained. There was a significant corre-
lation between the presence of nuclear reactivity and higher
S-phase conrent (0.02>P>0.01; x2 9.11; 2 df) and greater
than 15% of cells staining (0.05>P>0.02; x2 10.10; 4 df).
Table I Correlation between histological grade
of carcinomas and the extent of nuclear staining
with the Ki-67 antibody
Histological grade
Reactivity with
Ki-67 I II III
Nuclear staining
25-60% 0 2 1
15-25% 0 8 5
5-15% 1 8 8
<5% 2 11 7
Cytoplasmic staining
or negative 4 30 6
7 59 27
Table II Relationship between S-phase content of breast carcinomas
and staining with Ki-67 antibody; the histological grade of the
tumours in each category is included in brackets
S-phase content
Staining Low Medium High
Nuclear 25-60% 1 (II) 0 2 (II; III)
15-25% 1 (II) 4 (411) 4 (211;2111)
5-15% 0 1 (II) 2 (2III)
<5% 0 4 (I; II; 5 (311; 2III)
2III)
Cytoplasmic or 9 (21;711) 10 (711; 2111 4 (211; III
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Discussion
Unlike other studies which have been concerned with the
application of Ki-67 to breast carcinomas (Gerdes et al.,
1986; Lelle et al., 1987) we have been unable to detect any
evidence of nuclear reactivity in a substantial group of breast
carcinomas. In view of this a small group of tumours have
been considered in some depth to assess the stability of the
nuclear antigen. There was no variation between samples
stained immediately and after storage, albeit upto only seven
days, and there was also no alteration after variable periods
of section drying at room temperature. Storage of cut
sections at -20°C did not affect nuclear reactivity. The
evidence from this study suggests that lability of the antigen
should not be a problem. Frozen tissue from 45 carcinomas
examined with the Ki-67 antibody were concurrently as-
sessed for and shown to express transferrin and epidermal
growth factor receptors, the data for which are already
published (Walker & Camplejohn, 1986), indicating that the
sections investigated were immunologically reactive. No
significant differences were obtained between two and three
stage immunohistochemical methods.
The main difference between the group of tumours studied
after storage and those examined shortly after excision was
the presence of cytoplasmic staining in the carcinoma cells,
and in adjacent normal breast epithelium. Besides variation
in storage time, the second group of carcinomas were
examined with a different batch of antibody. It is difficult to
assess now whether there were any differences in the
clonality of the antibodies received at different times.
However, it would seem unlikely that storage, and hence
diffusion from nucleus to cytoplasm, would result in the type
of cytoplasmic staining illustrated. The significance of this
staining is not known, but it is unrelated to proliferative
activity (Gerdes et al., 1983).
Overall there was a correlation between the presence of
nuclear reactivity and poorer differentiation of the carci-
nomas and a high S-phase content. The DNA aneuploid
tumours had a higher frequency of nuclear staining than the
DNA diploid ones. The extent of the nuclear staining did
not correlate with the degree of differentiation. Gerdes et al.
(1986) found a wide scatter of nuclear reactivity within each
histological grade, although a significant correlation between
extent of staining and grade was found. No direct
correlations between S-phase content of carcinomas, as
determined by DNA flow cytometry, have been reported. In
comparison to grade, there was a correlation between the
extent of nuclear reactivity with Ki-67, using a cut-off point
of 15%, and S-phase content. However, there were still a
group of carcinomas with medium and high S-phase contents
which had no evidence of staining.
The heterogeneity of staining with Ki-67 was quite striking
in many carcinomas. To overcome this problem 2,000 plus
nuclei were evaluated which is greater than in other studies
(Gerdes et al., 1986; Lelle et al., 1987), and this type of
evaluation may account for the greater number of carci-
nomas with lower percentage nuclear staining seen in the
present study.
Within this study we have identified several groups of
tumours: those with no Ki-67 staining, low grade and S-
phase content; those with no Ki-67 staining but of higher
grade and high S-phase content; carcinomas with high
percentage of nuclear staining with Ki-67 but lower grade
and S-phase content, and those tumours in which extent of
Ki-67 staining, grade and S-phase content parallel one
another. Since the major reason for assessing proliferative
content of breast carcinomas is as a prognostic determinant,
it will be of particular interest to follow the clinical outcome
of those patients whose tumours fell into the middle two
groups. A comparison of those with no Ki-67 reactivity but
high S-phase content and grade with those exhibiting the
converse should reveal which of these determinants is of
greater prognostic value. At the present time insufficient
clinical follow-up is available.
We are grateful to Sheila J. Day, Julie Alder and Michael G. Stones
for excellent technical assistance, Peter Wells-Jordan for help with
photography and Mrs Wendy Pitts for typing the manuscript.
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